Retour
Fourchette du Jour
3,85 €
5,50 €
Fourchette 52 Semaines
3,17 €
5,50 €
Volume
2 643
Moyenne 50J / 200J
4,46 €
/
4,48 €
Clôture Précédente
4,26 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 2,6 | 0,2 |
| P/B | 0,3 | 3,0 |
| ROE % | 9,7 | 3,6 |
| Net Margin % | 15,5 | 3,8 |
| Rev Growth 5Y % | 6,7 | 9,9 |
| D/E | 0,8 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
0,00 €
0,00 € – 0,00 €
|
10,06B | 0 |
| FY2026 |
0,00 €
0,00 € – 0,00 €
|
9,20B | 0 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-12 | N/A | 0,13 € | — |
| 2025-11-12 | N/A | 0,13 € | — |
| 2025-08-06 | N/A | 0,12 € | — |
| 2025-04-23 | N/A | -0,04 € | — |
| 2024-12-31 | N/A | 0,02 € | — |
| 2024-11-13 | N/A | 0,11 € | — |
| 2024-07-25 | N/A | 0,15 € | — |
| 2024-04-26 | N/A | 0,12 € | — |
Dividend History
Yield
0,04%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 02, 2026 | Mar 09, 2026 | 0,05 € | 4,75% |
| Dec 30, 2025 | — | 0,04 € | 5,32% |
| Oct 06, 2025 | — | 0,04 € | 4,68% |
| Jun 30, 2025 | — | 0,05 € | 4,24% |
| Apr 04, 2025 | — | 0,05 € | 5,79% |
| Jan 10, 2025 | — | 0,02 € | 7,39% |
| Jan 06, 2025 | — | 0,03 € | 6,26% |
| Oct 04, 2024 | — | 0,04 € | 4,40% |
| Aug 01, 2024 | — | 0,02 € | 4,80% |
| Jul 01, 2024 | — | 0,02 € | 4,24% |
| May 31, 2024 | — | 0,02 € | 3,86% |
| May 02, 2024 | — | 0,02 € | 3,09% |
| Mar 22, 2024 | — | 0,02 € | 3,07% |
| Mar 01, 2024 | — | 0,02 € | 2,69% |
| Feb 08, 2024 | — | 0,02 € | 2,65% |
| Dec 28, 2023 | Jan 07, 2024 | 0,05 € | 1,95% |
| Oct 05, 2023 | Jan 07, 2024 | 0,05 € | 2,38% |
| Jul 06, 2023 | Jan 07, 2024 | 0,05 € | 1,17% |
| Dec 29, 2022 | Jan 12, 2023 | 0,06 € | 2,00% |
| Jul 01, 2022 | Jan 12, 2023 | 0,06 € | 3,15% |
Points Clés
Revenue grew 6,71% annually over 5 years — modest growth
Earnings declined -10,86% over the past year
Net margin of 15,53% shows strong profitability
Generating 1,78B in free cash flow
P/E of 2,64 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,26%
Croissance
Revenue Growth (5Y)
6,71%
Revenue (1Y)3,45%
Earnings (1Y)-10,86%
FCF Growth (3Y)5,88%
Qualité
Return on Equity
9,71%
ROIC5,96%
Net Margin15,53%
Op. Margin22,57%
Sécurité
Debt / Equity
0,75
Current Ratio1,47
Interest Coverage1,67
Valorisation
P/E Ratio
2,64
Forward P/EN/A
P/B Ratio0,25
EV/EBITDA6,24
Dividend Yield0,04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,45% | Revenue Growth (3Y) | -1,37% |
| Earnings Growth (1Y) | -10,86% | Earnings Growth (3Y) | -14,83% |
| Revenue Growth (5Y) | 6,71% | Earnings Growth (5Y) | -2,64% |
| Profitability | |||
| Revenue (TTM) | 7,70B | Net Income (TTM) | 1,20B |
| ROE | 9,71% | ROA | 4,75% |
| Gross Margin | 59,04% | Operating Margin | 22,57% |
| Net Margin | 15,53% | Free Cash Flow (TTM) | 1,78B |
| ROIC | 5,96% | FCF Growth (3Y) | 5,88% |
| Safety | |||
| Debt / Equity | 0,75 | Current Ratio | 1,47 |
| Interest Coverage | 1,67 | ||
| Dividends | |||
| Dividend Yield | 0,04% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 2,64 | Forward P/E | N/A |
| P/B Ratio | 0,25 | P/S Ratio | 0,41 |
| PEG Ratio | -1,11 | Forward PEG | N/A |
| EV/EBITDA | 6,24 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 56,30% | ||
| Market Cap | 3,15B | Enterprise Value | 10,84B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7,70B | 7,44B | 7,91B | 7,55B | 5,94B |
| Net Income | 1,20B | 1,34B | 1,65B | 1,70B | 1,33B |
| EPS (Diluted) | 1,89 | 2,10 | 2,58 | 2,65 | 2,08 |
| Gross Profit | 4,55B | 4,38B | 5,00B | 4,76B | 3,80B |
| Operating Income | 1,74B | 1,80B | 2,29B | 2,64B | 2,04B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 25,16B | 24,56B | 24,51B | 23,76B | 19,82B |
| Total Liabilities | 12,63B | 12,46B | 12,99B | 13,10B | 9,98B |
| Shareholders' Equity | 12,52B | 12,10B | 11,50B | 10,65B | 9,83B |
| Total Debt | 9,34B | 9,40B | 9,96B | 9,68B | 7,41B |
| Cash & Equivalents | 1,65B | 1,74B | 2,58B | 2,86B | 2,29B |
| Current Assets | 6,05B | 6,68B | 8,08B | 8,53B | 6,49B |
| Current Liabilities | 4,11B | 3,94B | 4,64B | 5,23B | 2,78B |